Randomized Clinical Trials (RCTs)
The Gold Standard of Clinical
Research
Areej alnomsi
Student ID: 402003258
What is a Randomized Clinical
Trial?
A scientific study that assigns participants randomly to test a treatment or
intervention.
Objective: Evaluate efficacy and safety with minimal bias.
Considered the highest level of clinical evidence.
Key Features of RCTs
Randomization: Equal chance of receiving intervention or control.
Control Group: Standard care or placebo for comparison.
Blinding: Concealing allocation to prevent bias.
RCT Workflow
1. Define research question and objectives.
2. Recruit eligible participants.
3. Randomly assign groups.
4. Apply intervention or control.
5. Monitor outcomes objectively.
6. Analyze results statistically.
Types of RCTs
Parallel: Two groups receive different treatments simultaneously.
Crossover: Participants receive both treatments in sequence.
Cluster: Groups (e.g., hospitals) randomized instead of individuals.
Factorial: Tests multiple interventions simultaneously.
Role of Randomization
Ensures group comparability at baseline.
Minimizes selection bias.
Supports causal inference.
Blinding in RCTs
Single-blind: Only participants are unaware.
Double-blind: Both participants and researchers are unaware.
Triple-blind: Analysts are also blinded to group allocation.
Statistical Considerations
Sample size: Determined via power analysis.
Random sequence generation: Computer or table-based.
Intention-to-treat analysis: Includes all participants as randomized.
Advantages of RCTs
High internal validity.
Controlled environment for testing.
Minimizes bias and confounding.
Limitations of RCTs
Expensive and time-intensive.
Limited generalizability to real-world settings.
May raise ethical concerns in some contexts.
Real-World Examples
COVID-19 Vaccine Trials (e.g., Pfizer/BioNTech RCTs)
Hypertension treatment trials (e.g., SPRINT Trial)
Behavioral interventions in digital health
Ethics in RCTs
Mandatory informed consent.
Independent ethics committee review.
Trial registration for transparency.
References
Bothwell LE, Greene JA. (2021). RCTs and Medical Evidence Evolution.
NEJM.
Ioannidis JP. (2020). Importance of Randomization in Clinical Research.
JAMA.
Gertler PJ, et al. (2022). The Impact of RCTs in Global Health. Lancet Global
Health.